Home » Topics » Medical technology

Medical technology
RSS

Other News To Note

Dec. 15, 2004

Inex Cuts Nearly Two-Thirds Of Staff, Plans New Marqibo Trial

Dec. 15, 2004

By Aaron Lorenzo

ExonHit Hits First Milestone In Partnership With Allergan

Dec. 15, 2004

By James Etheridge

Chroma Raises £5M More To Add To Second Round

Dec. 15, 2004

Other News To Note

Dec. 15, 2004

Pepscan Enters Vaccine Deal Aimed At Cytokine With Cytos

Dec. 15, 2004

By Cormac Sheridan

New Antibiotic Class Might Thrash Drug-Resistant TB

Dec. 15, 2004

By Sharon Kingman

Corixa Sells Bexxar To GSK, Cuts Staff By 160 Employees

Dec. 15, 2004

With slower-than-expected sales growth of Bexxar, Corixa Corp. decided to turn worldwide rights for the non-Hodgkin's lymphoma product over to partner GlaxoSmithKline plc. (BioWorld Today)

Cresset Using FieldScreen As Drug Discovery Platform

Dec. 15, 2004

Cutting Off TB's Energy Source Might Be Novel Line Of Attack

Dec. 15, 2004

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...